Standard

THE RELATIONSHIP BETWEEN ELEVATED LIPOPROTEIN(A) LEVELS AND ANTIATHEROGENIC TOLL-LIKE RECEPTOR GENES POLYMORPHISM IN FAMILIAL HYPERCHOLESTEROLEMIA. / Muzalevskaya, M.; Afanasieva, O.; Razgildina, N.; Urazgildeeva, S. A.; Miroshnikova, V. V.; Gurevich, V. S.

In: Atherosclerosis, Vol. 331, 08.2021, p. E116-E116.

Research output: Contribution to journal › Meeting Abstract › peer-review

Harvard

Muzalevskaya, M, Afanasieva, O, Razgildina, N, Urazgildeeva, SA, Miroshnikova, VV & Gurevich, VS 2021, 'THE RELATIONSHIP BETWEEN ELEVATED LIPOPROTEIN(A) LEVELS AND ANTIATHEROGENIC TOLL-LIKE RECEPTOR GENES POLYMORPHISM IN FAMILIAL HYPERCHOLESTEROLEMIA', Atherosclerosis, vol. 331, pp. E116-E116. https://doi.org/10.1016/j.atherosclerosis.2021.06.342

APA

Muzalevskaya, M., Afanasieva, O., Razgildina, N., Urazgildeeva, S. A., Miroshnikova, V. V., & Gurevich, V. S. (2021). THE RELATIONSHIP BETWEEN ELEVATED LIPOPROTEIN(A) LEVELS AND ANTIATHEROGENIC TOLL-LIKE RECEPTOR GENES POLYMORPHISM IN FAMILIAL HYPERCHOLESTEROLEMIA. Atherosclerosis, 331, E116-E116. https://doi.org/10.1016/j.atherosclerosis.2021.06.342

Vancouver

Muzalevskaya M, Afanasieva O, Razgildina N, Urazgildeeva SA, Miroshnikova VV, Gurevich VS. THE RELATIONSHIP BETWEEN ELEVATED LIPOPROTEIN(A) LEVELS AND ANTIATHEROGENIC TOLL-LIKE RECEPTOR GENES POLYMORPHISM IN FAMILIAL HYPERCHOLESTEROLEMIA. Atherosclerosis. 2021 Aug;331:E116-E116. https://doi.org/10.1016/j.atherosclerosis.2021.06.342

Author

Muzalevskaya, M. ; Afanasieva, O. ; Razgildina, N. ; Urazgildeeva, S. A. ; Miroshnikova, V. V. ; Gurevich, V. S. / THE RELATIONSHIP BETWEEN ELEVATED LIPOPROTEIN(A) LEVELS AND ANTIATHEROGENIC TOLL-LIKE RECEPTOR GENES POLYMORPHISM IN FAMILIAL HYPERCHOLESTEROLEMIA. In: Atherosclerosis. 2021 ; Vol. 331. pp. E116-E116.

BibTeX

@article{db3cc632d88a419fbcf3f223274a0731,
title = "THE RELATIONSHIP BETWEEN ELEVATED LIPOPROTEIN(A) LEVELS AND ANTIATHEROGENIC TOLL-LIKE RECEPTOR GENES POLYMORPHISM IN FAMILIAL HYPERCHOLESTEROLEMIA",
abstract = " It was recently demonstrated that G allele of the rs4986790 polymorphism (Asp299Gly) of TLR4 Gene (AG genotype) has been associated with decreased development of atherosclerosis. The aim of the study was to analyze the relationships between polymorphism of TLR4 Gene and lipid disorders in patients with familial hypercholesterolemia (FH) since it is known that a part of FH patients do not manifest cardiovascular event regardless elevated low density lipoprotein cholesterol (LDL-C) levels.",
author = "M. Muzalevskaya and O. Afanasieva and N. Razgildina and Urazgildeeva, {S. A.} and Miroshnikova, {V. V.} and Gurevich, {V. S.}",
year = "2021",
month = aug,
doi = "10.1016/j.atherosclerosis.2021.06.342",
language = "Английский",
volume = "331",
pages = "E116--E116",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - THE RELATIONSHIP BETWEEN ELEVATED LIPOPROTEIN(A) LEVELS AND ANTIATHEROGENIC TOLL-LIKE RECEPTOR GENES POLYMORPHISM IN FAMILIAL HYPERCHOLESTEROLEMIA

AU - Muzalevskaya, M.

AU - Afanasieva, O.

AU - Razgildina, N.

AU - Urazgildeeva, S. A.

AU - Miroshnikova, V. V.

AU - Gurevich, V. S.

PY - 2021/8

Y1 - 2021/8

N2 - It was recently demonstrated that G allele of the rs4986790 polymorphism (Asp299Gly) of TLR4 Gene (AG genotype) has been associated with decreased development of atherosclerosis. The aim of the study was to analyze the relationships between polymorphism of TLR4 Gene and lipid disorders in patients with familial hypercholesterolemia (FH) since it is known that a part of FH patients do not manifest cardiovascular event regardless elevated low density lipoprotein cholesterol (LDL-C) levels.

AB - It was recently demonstrated that G allele of the rs4986790 polymorphism (Asp299Gly) of TLR4 Gene (AG genotype) has been associated with decreased development of atherosclerosis. The aim of the study was to analyze the relationships between polymorphism of TLR4 Gene and lipid disorders in patients with familial hypercholesterolemia (FH) since it is known that a part of FH patients do not manifest cardiovascular event regardless elevated low density lipoprotein cholesterol (LDL-C) levels.

UR - https://www.mendeley.com/catalogue/d875962b-08b2-3c0f-9a35-0773b02b7978/

U2 - 10.1016/j.atherosclerosis.2021.06.342

DO - 10.1016/j.atherosclerosis.2021.06.342

M3 - тезисы

VL - 331

SP - E116-E116

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

ER -

ID: 88241440